Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, NM 87545, USA.
Viruses. 2020 Sep 12;12(9):1018. doi: 10.3390/v12091018.
Many countries and US states have mandatory statues that require reporting of HIV clinical data including genetic sequencing results to the public health departments. Because genetic sequencing is a part of routine care for HIV infected persons; health departments have extensive sequence collections spanning years and even decades of the HIV epidemic. How should these data be used (or not) in public health practice? This is a complex; multi-faceted question that weighs personal risks against public health benefit. The answer is neither straightforward nor universal. However; to make that judgement-of how genetic sequence data should be used in describing and combating the HIV epidemic-we need a clear image of what a phylogenetically enhanced HIV surveillance system can do and what benefit it might provide. In this paper, we present a positive case for how up-to-date analysis of HIV sequence databases managed by health departments can provide unique and actionable information of how HIV is spreading in local communities. We discuss this question broadly, with examples from the US, as it is globally relevant for all health authorities that collect HIV genetic data.
许多国家和美国各州都有强制性法规,要求向公共卫生部门报告 HIV 临床数据,包括基因测序结果。由于基因测序是 HIV 感染者常规护理的一部分;因此卫生部门拥有广泛的序列集,涵盖了 HIV 流行的数年甚至数十年。这些数据应该如何在公共卫生实践中使用(或不使用)?这是一个复杂的、多方面的问题,需要权衡个人风险与公共卫生效益。答案既不简单也不普遍。然而;为了判断基因序列数据在描述和抗击 HIV 流行方面应该如何使用,我们需要清楚地了解进化增强型 HIV 监测系统可以做什么,以及它可能提供什么好处。在本文中,我们提出了一个积极的案例,说明卫生部门管理的 HIV 序列数据库的最新分析如何提供有关 HIV 在当地社区传播方式的独特和可操作的信息。我们广泛地讨论了这个问题,并以美国为例,因为所有收集 HIV 遗传数据的卫生当局在全球范围内都与这个问题相关。